Cassava Sciences reports positive simufilam data with SavaDx in mid-stage Alzheimer’s study
July 26 2021 - 08:47AM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
Cassava Sciences (NASDAQ:SAVA)
Historical Stock Chart
From Feb 2024 to Mar 2024
Cassava Sciences (NASDAQ:SAVA)
Historical Stock Chart
From Mar 2023 to Mar 2024